Cargando…
P321: TNF-MEDIATED CELL DEATH: AN ACTIONABLE TARGET FOR IMMUNOTHERAPY IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Autores principales: | Dourthe, Marie-Emilie, Lengline, Etienne, Charbonnier, Guillaume, Latiri, Mehdi, Saji, Chaimae, Cieslak, Agata, Simonin, Mathieu, Ifrah, Norbert, Dombret, Hervé, Hermine, Olivier, Boissel, Nicolas, Baruchel, André, Ghysdael, Jacques, Macintyre, Elizabeth, Tran-Quang, Christine, Andrieu, Guillaume, Asnafi, Vahid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428464/ http://dx.doi.org/10.1097/01.HS9.0000968196.97465.b3 |
Ejemplares similares
-
Harnessing the MYB-dependent TAL1 5’super-enhancer for targeted therapy in T-ALL
por: Smith, Charlotte, et al.
Publicado: (2023) -
The oncogenetic landscape and clinical impact of BCL11B alterations in adult and pediatric T-cell acute lymphoblastic leukemia
por: Dourthe, Marie Emilie, et al.
Publicado: (2023) -
S106: METABOLIC PLASTICITY REVEALS A TARGETABLE VULNERABILITY IN LEUKEMIA
por: Andrieu, Guillaume, et al.
Publicado: (2023) -
Targeting IRAK1 in T-Cell acute lymphoblastic leukemia
por: Dussiau, Charles, et al.
Publicado: (2015) -
Impact of T-cell Receptor Status on Mutational Landscape and Outcome in T-ALL
por: Dourthe, Marie Emilie, et al.
Publicado: (2023)